Fees, Snags in Russia Drive Off Trial Sponsors

Clinical Trials Advisor
Costly local clinical trials required to register both novel and generic drugs in Russia are discouraging clinical trials in that country, according to the Russia-based Association of Clinical Trials Organizations (ACTO).

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00